AstraZeneca and TB Alliance Collaborate to Address TB
Debbie Tranter
Abstract
AstraZeneca has signed a research agreement with the TB Alliance to build a robust portfolio of affordable drugs within the shortest time possible to combat the TB epidemic.
Add comment

This work is licensed under a Creative Commons Attribution 3.0 License.